Clinnova-MS: A Prospective Cohort Study of Patients With Multiple Sclerosis (Switzerland)
This prospective cohort study, part of the Clinnova programme, aims to identify clinical imaging and omics characteristics linked to early multiple sclerosis and its progression to a progressive form. It also seeks to investigate digital biomarkers that enable continuous clinical monitoring of patients.
This prospective cohort study, part of the Clinnova programme, aims to identify clinical imaging and omics characteristics linked to early multiple sclerosis and its progression to a progressive form. It also seeks to investigate digital biomarkers that enable continuous clinical monitoring of patients.
The study’s focus on digital biomarkers and continuous monitoring aligns with Switzerland’s growing interest in applying AI to improve disease tracking and personalized care.
Original source record. Open the original record to verify the underlying announcement.